ICON - ICX

Option chain shows key data for Icon Energy's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Icon Energy.

Icon Energy (NASDAQ:ICON) Stock, Option Chain

Icon Energy

Iconix Brand Group

Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEHL

AEMD

AMEH

AMST

ANVS

APTO

APTX

BAOS

BIVI

BMRA

BYFC

CARV

CMCM

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

CRIS

DBGI

DCRC

DIBS

EQOS

FMTX

GLTO

HTBX

ICON

JAKK

JANX

JZXN

LBPH

LOOP

LXEH

MDLA

MDLY

MEDS

NCTY

NOVN

ORPH

OXBR

PHCF

PROG

PRPH

PTGX

PTIX

QUMU

RAMP

RCON

SAVA

SBEV

SENS

SIEB

TASK

TYME

UONE

UPST

VRTX

VXRT

ZIVO

Gainers


	Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share.


64 Biggest Movers From Friday

Iconix Brand To Go Private In $585 Million Deal

Intraday Update

OSAT

PGEN

SNPX

Gainers


	Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share.


46 Stocks Moving In Friday&#39;s Mid-Day Session

Icon Energy Corp

Icon - United States Dollar

Icon Energy Ltd

ICON MEDIA HOLDINGS INC by Icon Media Holdings, Inc.

Icon Media Holdings Inc

Icon PLC

Iconic Brands Inc

ICONIC MINERALS LTD NEW by Iconic Minerals Ltd

Iconic Minerals Ltd

Iconic Minerals Ltd Ordinary Shares - New

Iconic Token

iConsumer Corp

Icon Energy Corp. ("Icon" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>), an international shipping company that provides worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels, announces its financial results for the nine-month period ended September 30, 2024, (the "Reporting Period") and declares cash dividend of $0.085 per common share.
Financial Highlights for the Reporting Period
<ul>
<li>Revenue, net of $3.6 million, up $0.4 million from the first nine months of 2023</li>
<li>Operating profit of $0.6 million, compared to $0.7 million during the nine-month period ended September 30, 2023</li>
<li>Net income of $0.6 million, compared to $0.8 million during the nine-month period ended September 30, 2023</li>
<li>EBITDA(1) of $1.5 million, equal to the same period last year</li>
</ul>

Earnings

Icon Energy Corp. Reports 9-Month Revenue Of $3.6 Million; EPS $0.06 Vs $3.76 YoY

Vessel Delivery
On September 23, 2024, Icon successfully took delivery of the M/V Bravo, the Kamsarmax dry bulk carrier it had agreed to acquire from an unaffiliated third-party, as previously announced on August 8, 2024.
Icon has secured a time charter for the M/V Bravo, whereby the vessel will be employed by an international commodity trading conglomerate for a period of 11 to 14 months, at a floating daily hire rate linked to the Baltic Panamax Index, which is expected to commence in the coming days, upon completion of the customary change of ownership logistics.
Financing Update
We signed a new term loan facility for up to $91.5 million with a leading international financial institution, pursuant to the financing term sheet announced on August 23, 2024.
On September 19, 2024, we borrowed an amount of $16.5 million under the term loan facility to finance a portion of the purchase price of the M/V Bravo and to leverage Icon's existing Panamax dry bulk carrier, the M/V Alfa. The term loan facility is secured by a first priority mortgage on the vessels, an assignment of earnings and insurances, and a pledge of the earnings accounts for the vessels, among other customary security, and contains financial and other covenants customary for transactions of this type. The term loan facility has a four-year tenor, and outstanding amounts thereunder bear interest at 3.95% over SOFR.
The balance amount of $75 million may be made available to us, in whole or in parts, to finance future vessel acquisitions. This balance amount remains uncommitted, free of interest or other fees, and we are not obliged to borrow it, or any part thereof. The terms of borrowing the balance amount, or any part thereof, will be determined at the time it is requested.

Financing

Icon Energy Corp. Announces The Delivery Of M/V Bravo And The Signing Of A Term Loan Facility For Up To $91.5M

Icon Energy Corp. 1H Revenue $2.7M, Up 18% YoY

WIIM

Icon Energy shares are trading higher after Maxim Group initiated coverage on the stock with a Buy rating and announced a price target of $7.

Maxim Group analyst Tate Sullivan initiates coverage on Icon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) with a Buy rating and announces Price Target of $7.

Price Target

Initiation

Analyst Ratings

Maxim Group Initiates Coverage On Icon Energy with Buy Rating, Announces Price Target of $7

Earnings Preview
We plan to announce our unaudited interim financial results for the six-month period ended June 30, 2024, on or before September 10, 2024, expecting to report:
<ul>
<li>Revenue, net between $2.6 million and $2.8 million, an increase of between 15% and 20% compared to the corresponding period of 2023;</li>
<li>Operating profit between $0.9 million and $1.1 million, an increase of between 42% and 50% compared to the corresponding period of 2023; and</li>
<li>Net income between $0.9 million and $1.1 million, an increase of about 40% to 45% compared to the corresponding period of 2023. &nbsp;</li>
</ul>
The above financial results are preliminary and based on information available to us as of the date of this press release. We have not finalized our financial statement closing process for the six-month period ended June 30, 2024. During the course of that process, we may identify items that would require us to make adjustments, which may be material to the information provided above. As a result, the information above constitutes forward-looking statements and is subject to risks and uncertainties, including possible adjustments to these preliminary results. We are providing this information on a one-time basis only and do not intend to update this information prior to the final earnings release for each reporting period.

Guidance

Icon Energy Sees 1H Revenue Of $2.6M-$2.8M, Up 15%-20% YoY

Icon Energy Announces Acquisition Of Kamsarmax Dry Bulk Carrier For $17.57M; To Be Financed With Cash On Hand And New Senior Secured Facility

IPOs

Icon Energy Shares Open For Trade At $3.80/Share; IPO Priced At $4/Share On 1.25M Shares

Trading Halt: Halt status updated at 11:00:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Icon Energy Prices IPO Of 1.25M Shares At $4.00/Share

&nbsp;
<h3>Gainers</h3>
<ul>
<li>Iconix Brand Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) shares increased by 6.68% to $3.35 during Friday&#39;s pre-market session. The company&#39;s market cap stands at $48.5 million.</li>
<li>Vinco Ventures (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIG#NASDAQ">BBIG</a>) shares increased by 5.12% to $4.1. The company&#39;s market cap stands at $171.2 million.</li>
<li>Smith &amp; Wesson Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) shares increased by 4.81% to $20.88. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q4 earnings report came out yesterday.</li>
<li>New Oriental Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) stock increased by 4.19% to $7.95. The company&#39;s market cap stands at $13.5 billion.</li>
<li>Arcimoto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUV#NASDAQ">FUV</a>) shares rose 4.12% to $15.03. The market value of their outstanding shares is at $537.6 million.</li>
<li>TAL Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) shares increased by 3.68% to $21.38. The company&#39;s market cap stands at $13.7 billion.</li>
</ul>
&nbsp;
&nbsp;
<h3>Losers</h3>
&nbsp;
<ul>
<li>FAT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATBP#NASDAQ">FATBP</a>) stock declined by 12.4% to $20.5 during Friday&#39;s pre-market session.</li>
<li>Moxian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOXC#NASDAQ">MOXC</a>) stock fell 9.0% to $10.73. The market value of their outstanding shares is at $207.5 million.</li>
<li>Zovio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVO#NASDAQ">ZVO</a>) shares declined by 7.85% to $2.7. The company&#39;s market cap stands at $89.9 million.</li>
<li>Toyota Motor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) shares declined by 3.08% to $179.5. The market value of their outstanding shares is at $250.9 billion.</li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) shares fell 2.88% to $2.7. The company&#39;s market cap stands at $55.5 million.</li>
<li>ToughBuilt Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLT#NASDAQ">TBLT</a>) shares declined by 2.4% to $0.81. The market value of their outstanding shares is at $66.1 million.</li>
</ul>
&nbsp;
&nbsp;

BBIG

New Oriental Education & Technology Group

FATBP

MOXC

SWBI

TBLT

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Smith &amp; Wesson Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) stock increased by 3.61% to $20.64 during Thursday's after-market session. Smith &amp; Wesson Brands's trading volume hit 434.5K shares by close, accounting for 29.13% of its average volume over the last 100 days. The company's market cap stands at $1.0 billion. As per the press release, Q4 earnings came out today. </li>
<li>Dave &amp; Buster's Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>) shares rose 1.99% to $40.85. At the close, Dave &amp; Buster's Enter's trading volume reached 111.0K shares. This is 7.59% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.9 billion. </li>
<li>Yunhong CTI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTIB#NASDAQ">CTIB</a>) stock increased by 1.93% to $2.11. Yunhong CTI's trading volume hit 205 shares by close, accounting for 0.08% of its average volume over the last 100 days. The market value of their outstanding shares is at $9.4 million. </li>
<li>Vinco Ventures (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIG#NASDAQ">BBIG</a>) shares moved upwards by 1.79% to $3.97. Vinco Ventures's trading volume hit 35.3K shares by close, accounting for 0.34% of its average volume over the last 100 days. The market value of their outstanding shares is at $165.8 million. </li>
<li>Iconix Brand Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) shares rose 1.59% to $3.19. This security traded at a volume of 2.5K shares come close, making up 1.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $46.1 million. </li>
<li>Puxin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEW#NYSE">NEW</a>) shares rose 1.45% to $1.74. This security traded at a volume of 18.1K shares come close, making up 2.25% of its average volume over the last 100 days. The market value of their outstanding shares is at $152.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Moxian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOXC#NASDAQ">MOXC</a>) stock decreased by 5.86% to $11.1 during Thursday's after-market session. Trading volume for this security closed at 3.0K, accounting for 0.11% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $214.6 million. </li>
<li>Trxade Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) stock declined by 4.61% to $4.35. Today's trading volume for this security ended up closing at 320 shares, which is 0.01 percent of its average volume over the last 100 days. The company's market cap stands at $35.3 million. </li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) shares decreased by 4.32% to $2.66. At the close, Amesite's trading volume reached 5.6K shares. This is 0.42% of its average volume over the last 100 days. The market value of their outstanding shares is at $54.7 million. </li>
<li>Comstock Holding Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHCI#NASDAQ">CHCI</a>) stock declined by 2.47% to $5.55. At the close, Comstock Holding Co's trading volume reached 300 shares. This is 0.07% of its average volume over the last 100 days. The company's market cap stands at $46.1 million. </li>
<li>Forward Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORD#NASDAQ">FORD</a>) shares fell 1.56% to $3.16. Forward Industries's trading volume hit 2.2K shares by close, accounting for 0.52% of its average volume over the last 100 days. The market value of their outstanding shares is at $31.4 million. </li>
<li>Koss (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOSS#NASDAQ">KOSS</a>) stock fell 1.47% to $23.55. Trading volume for this security closed at 2.0K, accounting for 0.08% of its average full-day volume over the last 100 days. The company's market cap stands at $200.5 million. </li>
</ul>

CHCI

CTIB

FORD

KOSS

PLAY

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

Iconix Brand Group Shares Spike Higher On Volume; Not Seeing Company News

<h2>What are Value Stocks?</h2>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>Below is a list of notable value stocks in the consumer cyclical sector:</h2>
<ol>
<li>OneWater Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) - P/E: 8.28</li>
<li>Green Brick Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRBK#NASDAQ">GRBK</a>) - P/E: 9.28</li>
<li>Tupperware Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUP#NYSE">TUP</a>) - P/E: 7.56</li>
<li>America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) - P/E: 9.82</li>
<li>Iconix Brand Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) - P/E: 2.02</li>
</ol>
OneWater Marine has reported Q2 earnings per share at 1.83, which has increased by 157.75% compared to Q1, which was 0.71. OneWater Marine does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Green Brick Partners saw a decrease in earnings per share from 0.58 in Q4 to 0.51 now. Green Brick Partners does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Most recently, Tupperware Brands reported earnings per share at 0.82, whereas in Q4 earnings per share sat at 0.14. The company's most recent dividend yield sits at 7.0%, which has increased by 2.0% from 5.0% last quarter. 
America's Car-Mart saw an increase in earnings per share from 2.85 in Q3 to 6.19 now. America's Car-Mart does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Iconix Brand Group has reported Q1 earnings per share at -0.22, which has increased by 79.25% compared to Q4, which was -1.06. Iconix Brand Group does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

CRMT

GRBK

ONEW

Overview Of Value Stocks In The Consumer Cyclical Sector

<h3>Gainers</h3>
<ul>
<li>Kanzhun Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bz#NASDAQ">BZ</a>) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share.</li>
<li>Novan, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/novn#NASDAQ">NOVN</a>) shares gained 62.4% to settle at $14.68 after the company reported the B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved statistical significance for the primary endpoint and no serious adverse events were reported.</li>
<li>Baosheng Media Group Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/baos#NASDAQ">BAOS</a>) surged 56.3% to close at $5.00.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) jumped 47.9% to close at $25.15 as the company priced its IPO at $17 per share.</li>
<li>TaskUs, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/task#NASDAQ">TASK</a>) surged 35.2% to close at $31.09 after the company priced its IPO at $23 per share.</li>
<li>Urban One, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uone#NASDAQ">UONE</a>) rose 33.2% to close at $20.58, amid a continued run up into Juneteenth, during which the stock saw a surge last year.</li>
<li>Progenity, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prog#NASDAQ">PROG</a>) gained 28.9% to settle at $3.21.</li>
<li>Iconix Brand Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icon#NASDAQ">ICON</a>) jumped 27.8% to close at $3.13.</li>
<li>Diginex Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eqos#NASDAQ">EQOS</a>) gained 25.8% to settle at $8.19.</li>
<li>Carver Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/carv#NASDAQ">CARV</a>) jumped 24.2% to close at $15.44 amid a continued run up into Juneteenth, during which the stock saw a surge last year.</li>
<li>Xinyuan Real Estate Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xin#NYSE">XIN</a>) climbed 23.6% to settle at $3.62. Xinyuan Real Estate shares gained 14% on Thursday after the company highlighted completion of five newly constructed properties.</li>
<li>Vaxart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vxrt#NASDAQ">VXRT</a>) surged 21.9% to settle at $8.74 after Piper Sandler initiated coverage on the stock with an Overweight rating and $18 price target.</li>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) gained 21.7% to close at $18.09.</li>
<li>The9 Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncty#NASDAQ">NCTY</a>) surged 20.7% to settle at $19.37.</li>
<li>Apollo Medical Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ameh#NASDAQ">AMEH</a>) jumped 20.2% to settle at $48.34 after it was announced the company is set to join the S&amp;P SmallCap 600.</li>
<li>Broadway Financial Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/byfc#NASDAQ">BYFC</a>) jumped 19.9% to close at $3.07.</li>
<li>Chemomab Therapeutics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmmb#NASDAQ">CMMB</a>) jumped 19.6% to settle at $23.92 after gaining around 4% on Thursday.</li>
<li>GBS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbs#NASDAQ">GBS</a>) rose 18.7% to close at $4.31 after jumping around 19% on Thursday.</li>
<li>Protagonist Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptgx#NASDAQ">PTGX</a>) gained 17.1% to close at $39.64 after the company announced updated results from the ongoing Phase 2 study of rusfertide at the European Hematology Association 2021 Virtual Congress.</li>
<li>Annovis Bio, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anvs#NYSE">ANVS</a>) surged 16.8% to settle at $91.00. Annovis Bio recently announced preliminary data demonstrating that ANVS401 protects certain nerve cells from dying after being infected by gingipains, which has a potential role in developing Alzheimer&#39;s Disease.</li>
<li>Medallia, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mdla#NYSE">MDLA</a>) rose 16.7% to close at $33.11 amid reports the company is mulling a potential sale.</li>
<li>Oxbridge Re Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oxbr#NASDAQ">OXBR</a>) jumped 16.4% to settle at $3.05.</li>
<li>Brookdale Senior Living Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bkd#NYSE">BKD</a>) rose 16.3% to close at $8.49. Barclays upgraded Brookdale Senior Living from Equal-Weight to Overweight and raised the price target from $5 to $12.</li>
<li>Cassava Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sava#NASDAQ">SAVA</a>) gained 16.1% to close at $77.00 Cassava Sciences shares traded higher on Monday following FDA approval for Biogen&#39;s Alzheimer&#39;s candidate.</li>
<li>Amesite Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amst#NASDAQ">AMST</a>) surged 15.5% to close at $3.20 after surging over 25% on Thursday.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) gained 15.4% to settle at $49.40, rebounding from yesterday&#39;s selloff amid continued volatility in the stock from retail investor interest.</li>
<li>JAKKS Pacific, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jakk#NASDAQ">JAKK</a>) shares surged 15.2% to settle at $12.67.</li>
<li>ProPhase Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prph#NASDAQ">PRPH</a>) gained 14.5% to close at $6.40. The company recently announced the formation of ProPhase Precision Medicine and ProPhase Global Healthcare subsidiaries.</li>
<li>Zhihu Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zh#NYSE">ZH</a>) jumped 14.4% to settle at $11.55.</li>
<li>AcuityAds Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aty#NASDAQ">ATY</a>) rose 13.8% to close at $11.62. The company priced its IPO at $10.15 per share.</li>
<li>Longboard Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lbph#NASDAQ">LBPH</a>) gained 13.3% to close at $9.71.</li>
<li>Decarbonization Plus Acquisition Corporation III (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcrc#NASDAQ">DCRC</a>) rose 13.2% to settle at $12.44. Solid Power is exploring a SPAC merger with Decarbonization Plus Acquisition Corp III.</li>
<li>Protagenic Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptix#NASDAQ">PTIX</a>) climbed 11.2% to settle at $2.97 after jumping over 13% on Thursday. Recently, the company&rsquo;s S-3 filing showed registration for a $100 million mixed securities shelf offering.</li>
<li>Senseonics Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sens#NYSE">SENS</a>) rose 10.8% to close at $4.01 after jumping 18% on Thursday.</li>
<li>Aptinyx Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aptx#NASDAQ">APTX</a>) shares gained 9.1% to close at $3.50 on continued strength. The stock spiked Thursday after traders circulate a TipRanks titled &#39;2 &quot;Strong Buy&quot; Penny Stocks That Could Rally to $10 (or More)&#39; mentioning the stock.</li>
<li>Siebert Financial Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sieb#NASDAQ">SIEB</a>) rose 7.6% to close at $4.98.</li>
</ul>
&nbsp;
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Orphazyme A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orph#NASDAQ">ORPH</a>) shares dipped 55.6% to settle at $9.33 on Friday after jumping 302% on Thursday. On May 7, in the latest press statement put out by Orphazyme, it said its application for arimoclomol, which will be branded as MIPLYFFA for Niemann-Pick disease type C, is under priority review with the U.S. Food and Drug Administration &mdash; with the expected Prescription Drug User Fee Act action date of June 17.</li>
<li>Recon Technology, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcon#NASDAQ">RCON</a>) shares tumbled 51% to close at $6.24 on Friday. Recon Technology reports its Beijing BHD Petrolume subsidiary signed 2 contracts with Sinopec&#39;s North China E&amp;P Co.</li>
<li>Splash Beverage Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbev#NASDAQ">SBEV</a>) dropped 39.6% to settle at $3.28. Splash Beverage uplisted to NYSE American Exchange starting June 11.</li>
<li>Curis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cris#NASDAQ">CRIS</a>) fell 36.8% to close at $8.01 after the company announced updated data from its ongoing Phase 1/2 open-label, single arm, dose escalation and expansion trial of CA-4948.</li>
<li>Aptose Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apto#NASDAQ">APTO</a>) dipped 32% to settle at $3.76 after the company released highlights from its Luxeptinib clinical program.</li>
<li>Galecto, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glto#NASDAQ">GLTO</a>) shares declined 29.9% to close at $5.61 after surging 60% on Thursday.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehl#NASDAQ">AEHL</a>) declined 21.2% to settle at $3.23 after the company announced pricing of a registered direct offering.</li>
<li>Heat Biologics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htbx#NASDAQ">HTBX</a>) shares fell 20.4% to close at $7.64. Heat Biologics shares surged 40% on Thursday after the company filed for a patent titled &ldquo;GP96-Based Cancer Therapy.&rdquo;</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) shares fell 19.8% to close at $5.35. Trxade Health shares climbed 63% on Thursday after the company announced the launch of its MedCheks health passport app for iOS devices.</li>
<li>Loop Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/loop#NASDAQ">LOOP</a>) tumbled 18.6% to close at $11.20.</li>
<li>Forma Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fmtx#NASDAQ">FMTX</a>) fell 18.5% to close at $22.86 after the company highlighted the presentation of new Phase 1 data on etavopivat at the European Hematology Association 2021 Virtual Congress.</li>
<li>Qumu Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qumu#NASDAQ">QUMU</a>) declined 17.8% to close at $3.80 after Craig-Hallum downgraded the stock from Buy to Hold and announced a $6 price target.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxeh#NASDAQ">LXEH</a>) dropped 16.8% to close at $8.50.</li>
<li>Sphere 3D Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/any#NASDAQ">ANY</a>) fell 16.5% to close at $2.68. Sphere 3D shares surged over 60% on Thursday on continued strength after the company and Gryphon Digital on Wednesday announced an agreement to purchase 250,000 Certified Emission Reductions.</li>
<li>Puhui Wealth Investment Management Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phcf#NASDAQ">PHCF</a>) declined 16.1% to settle at $4.42.</li>
<li>Medley Management Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mdly#NYSE">MDLY</a>) shares fell 15.9% to close at $6.71. Medley Management shares jumped around 37% on Thursday as retail traders pushed the stock higher.</li>
<li>1stdibs.Com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dibs#NASDAQ">DIBS</a>) dropped 15.4% to settle at $24.11. The company recently priced its IPO at $20 per share.</li>
<li>Cheetah Mobile Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmcm#NYSE">CMCM</a>) fell 15.2% to settle at $2.34 after the company reported a sharp decline in quarterly sales.</li>
<li>Upstart Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) declined 14.3% to close at $125.51.</li>
<li>Digital Brands Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbgi#NASDAQ">DBGI</a>) fell 14.2% to settle at $3.44.</li>
<li>LiveRamp Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ramp#NYSE">RAMP</a>) fell 13.7% to close at $41.75.</li>
<li>Equillium, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eq#NASDAQ">EQ</a>) fell 12.2% to settle at $6.13 after the company reported topline data from the Phase 1b EQUATE study in first-line acute graft-versus-host-disease.</li>
<li>Biomerica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmra#NASDAQ">BMRA</a>) dropped 12.1% to close at $4.07.</li>
<li>Vertex Pharmaceuticals Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrtx#NASDAQ">VRTX</a>) slipped 11% to settle at $193.02 after the company reported it &quot;will not advance VX-864 into late-stage development and instead will advance additional novel small.&quot;</li>
<li>Jiuzi Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jzxn#NASDAQ">JZXN</a>) dipped 10.1% to close at $8.54.</li>
<li>ZIVO Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zivo#NASDAQ">ZIVO</a>) fell 9.8% to close at $4.70 after jumping around 6% on Thursday.</li>
<li>Aethlon Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aemd#NASDAQ">AEMD</a>) fell 5.9% to close at $6.49. Aethlon Medical shares fell 36% on Thursday after the company announced a 1.38 million share registered direct offering priced at $9 per share..</li>
<li>Tyme Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tyme#NASDAQ">TYME</a>) fell 5.7% to close at $1.50 as the company announced a breast cancer trial with Georgetown University named OASIS. Enrollment is expected to start in Q3 of 2021.</li>
</ul>

<ul>
<li>Iconix Brand Group Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icon#NASDAQ">ICON</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/06/g21528088/iconix-enters-into-definitive-agreement-to-be-acquired-in-go-private-transaction" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">has agreed to go private&nbsp;</a>through acquisition by an affiliate of Lancer Capital, LLC.</li>
<li>The deal is valued at $585 million, including debt.</li>
<li>Lancer Capital affiliate, Iconix Acquisition Corp will acquire all outstanding shares of Iconix at $3.15 a share in cash.</li>
<li>The offer represents a premium of 28.6% over Iconix&#39;s closing price of $2.45 on Thursday.</li>
<li>&quot;Today&#39;s announcement represents the culmination of a year-long examination by our Board of Directors of strategic alternatives for the Company,&quot; said Bob Galvin, Chief Executive Officer.</li>
<li>Iconix expects the deal to close by the end of the third quarter.</li>
<li>Price Action:&nbsp;ICON shares are trading&nbsp;higher by 27.8% at $3.13 on last check Friday.</li>
</ul>

<h3>Gainers</h3>
<ul>
<li>Kanzhun Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bz#NASDAQ">BZ</a>) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share.</li>
<li>Novan, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/novn#NASDAQ">NOVN</a>) shares jumped 73.3% to $15.67 after the company reported the B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved statistical significance for the primary endpoint and no serious adverse events were reported.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) gained 46.7% to $24.93 as the company priced its IPO at $17 per share.</li>
<li>Urban One, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uone#NASDAQ">UONE</a>) gained 37.1% to $21.19, amid a continued run up into Juneteenth, during which the stock saw a surge last year.</li>
<li>Iconix Brand Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icon#NASDAQ">ICON</a>) surged 27.7% to $3.13.</li>
<li>TaskUs, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/task#NASDAQ">TASK</a>) gained 26.8% to $29.17 after the company priced its IPO at $23 per share.</li>
<li>Aptinyx Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aptx#NASDAQ">APTX</a>) shares climbed 24.8% to $4.0050 on continued strength. The stock spiked Thursday after traders circulate a TipRanks titled &#39;2 &quot;Strong Buy&quot; Penny Stocks That Could Rally to $10 (or More)&#39; mentioning the stock.</li>
<li>GBS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbs#NASDAQ">GBS</a>) rose 24.5% to $4.52 after jumping around 19% on Thursday.</li>
<li>Vaxart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vxrt#NASDAQ">VXRT</a>) gained 22.3% to $8.77 after Piper Sandler initiated coverage on the stock with an Overweight rating and $18 price target.</li>
<li>Cassava Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sava#NASDAQ">SAVA</a>) rose 19.1% to $79.02. Cassava Sciences shares traded higher on Monday following FDA approval for Biogen&#39;s Alzheimer&#39;s candidate.</li>
<li>Carver Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/carv#NASDAQ">CARV</a>) gained 20.3% to $14.96 amid a continued run up into Juneteenth, during which the stock saw a surge last year.</li>
<li>Amesite Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amst#NASDAQ">AMST</a>) rose 18.6% to $3.2850 after surging over 25% on Thursday.</li>
<li>Broadway Financial Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/byfc#NASDAQ">BYFC</a>) gained 18.3% to $3.02.</li>
<li>Xinyuan Real Estate Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xin#NYSE">XIN</a>) gained 17.7% to $3.45. Xinyuan Real Estate shares gained 14% on Thursday after the company highlighted completion of five newly constructed properties.</li>
<li>Protagonist Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptgx#NASDAQ">PTGX</a>) gained 17.5% to $39.76 after the company announced updated results from the ongoing Phase 2 study of rusfertide at the European Hematology Association 2021 Virtual Congress.</li>
<li>Apollo Medical Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ameh#NASDAQ">AMEH</a>) surged 17.5% to $47.25 after it was announced the company is set to join the S&amp;P SmallCap 600.</li>
<li>AcuityAds Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aty#NASDAQ">ATY</a>) gained 15.2% to $11.77. The company priced its IPO at $10.15 per share.</li>
<li>Chemomab Therapeutics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmmb#NASDAQ">CMMB</a>) rose 14.6% to $22.92 after gaining around 4% on Thursday.</li>
<li>Siebert Financial Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sieb#NASDAQ">SIEB</a>) gained 14.7% to $5.31.</li>
<li>Annovis Bio, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anvs#NYSE">ANVS</a>) jumped 14% to $88.76. Annovis Bio recently announced preliminary data demonstrating that ANVS401 protects certain nerve cells from dying after being infected by gingipains, which has a potential role in developing Alzheimer&#39;s Disease.</li>
<li>Synaptogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpx#NASDAQ">SNPX</a>) gained 12.5% to $9.00. Synaptogenix recently announced an update on its ongoing National Institutes of Health (NIH) sponsored Phase 2b trial of Bryostatin-1 for moderately severe Alzheimer&#39;s disease (AD).</li>
<li>Senseonics Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sens#NYSE">SENS</a>) rose 11.9% to $4.05 after jumping 18% on Thursday.</li>
<li>Protagenic Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptix#NASDAQ">PTIX</a>) rose 9% to $2.91 after jumping over 13% on Thursday. Recently, the company&rsquo;s S-3 filing showed registration for a $100 million mixed securities shelf offering.</li>
<li>Precigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgen#NASDAQ">PGEN</a>) shares rose 5% to $7.34 after the company announced the primary endpoint of both the Phase 1b AG019 monotherapy and the Phase 2a AG019 combination therapy was met from the Phase 1b/2a study of AG019 ActoBiotics.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Recon Technology, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcon#NASDAQ">RCON</a>) shares dipped 58% to $5.35.</li>
<li>Recon Technology reports its Beijing BHD Petrolume subsidiary signed 2 contracts with Sinopec&#39;s North China E&amp;P Co.</li>
<li>Orphazyme A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orph#NASDAQ">ORPH</a>) fell 51% to $10.31 after jumping 302% on Thursday. On May 7, in the latest press statement put out by Orphazyme, it said its application for arimoclomol, which will be branded as MIPLYFFA for Niemann-Pick disease type C, is under priority review with the U.S. Food and Drug Administration &mdash; with the expected Prescription Drug User Fee Act action date of June 17.</li>
<li>Curis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cris#NASDAQ">CRIS</a>) dipped 36.1% to $8.11 after the company announced updated data from its ongoing Phase 1/2 open-label, single arm, dose escalation and expansion trial of CA-4948.</li>
<li>Aptose Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apto#NASDAQ">APTO</a>) dropped 30.7% to $3.83 after the company released highlights from its Luxeptinib clinical program.</li>
<li>Galecto, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glto#NASDAQ">GLTO</a>) shares fell 26.5% to $5.88 after surging 60% on Thursday.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) shares fell 24.1% to $5.06. Trxade Health shares climbed 63% on Thursday after the company announced the launch of its MedCheks health passport app for iOS devices.</li>
<li>Heat Biologics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htbx#NASDAQ">HTBX</a>) shares fell 23.5% to $7.33. Heat Biologics shares surged 40% on Thursday after the company filed for a patent titled &ldquo;GP96-Based Cancer Therapy.&rdquo;</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehl#NASDAQ">AEHL</a>) dropped 22.2% to $3.19 after the company announced pricing of a registered direct offering.</li>
<li>Sphere 3D Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/any#NASDAQ">ANY</a>) fell 21.2% to $2.5301. Sphere 3D shares surged over 60% on Thursday on continued strength after the company and Gryphon Digital on Wednesday announced an agreement to purchase 250,000 Certified Emission Reductions.</li>
<li>Forma Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fmtx#NASDAQ">FMTX</a>) dipped 19.4% to $22.61 after the company highlighted the presentation of new Phase 1 data on etavopivat at the European Hematology Association 2021 Virtual Congress.</li>
<li>Puhui Wealth Investment Management Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phcf#NASDAQ">PHCF</a>) fell 17.3% to $4.36.</li>
<li>Medley Management Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mdly#NYSE">MDLY</a>) shares fell 16.9% to $6.64. Medley Management shares jumped around 37% on Thursday as retail traders pushed the stock higher.</li>
<li>Qumu Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qumu#NASDAQ">QUMU</a>) dipped 14.5% to $3.95 after Craig-Hallum downgraded the stock from Buy to Hold and announced a $6 price target.</li>
<li>Biomerica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmra#NASDAQ">BMRA</a>) fell 14.5% to $3.96.</li>
<li>Cheetah Mobile Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmcm#NYSE">CMCM</a>) dropped 14.5% to $2.36 after the company reported a sharp decline in quarterly sales.</li>
<li>Loop Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/loop#NASDAQ">LOOP</a>) fell 14.4% to $11.77.</li>
<li>ZIVO Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zivo#NASDAQ">ZIVO</a>) fell 13.3% to $4.5190 after jumping around 6% on Thursday.</li>
<li>Jiuzi Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jzxn#NASDAQ">JZXN</a>) fell 13.1% to $8.25.</li>
<li>Vertex Pharmaceuticals Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrtx#NASDAQ">VRTX</a>) fell 9.4% to $196.33 after the company reported it &quot;will not advance VX-864 into late-stage development and instead will advance additional novel small.&quot;</li>
<li>Tyme Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tyme#NASDAQ">TYME</a>) fell 9.3% to $1.4429 as the company announced a breast cancer trial with Georgetown University named OASIS. Enrollment is expected to start in Q3 of 2021.</li>
<li>Orbsat Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osat#NASDAQ">OSAT</a>) fell 8.2% to $5.80 after jumping around 25% on Thursday.</li>
<li>Aethlon Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aemd#NASDAQ">AEMD</a>) fell 6.5% to $6.45. Aethlon Medical shares fell 36% on Thursday after the company announced a 1.38 million share registered direct offering priced at $9 per share..</li>
</ul>

46 Stocks Moving In Friday's Mid-Day Session

&nbsp;
<h3>Gainers</h3>
<ul>
<li>Iconix Brand Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) shares increased by 27.75% to $3.13 during Friday&#39;s regular session. As of 12:30 EST, Iconix Brand Group&#39;s stock is trading at a volume of 2.4 million, which is 1549.52% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $45.3 million.</li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) stock rose 21.23% to $3.36. Trading volume for Amesite&#39;s stock is 35.8 million as of 12:30 EST. This is 5967.48% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $69.0 million.</li>
<li>Jakks Pacific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAKK#NASDAQ">JAKK</a>) stock increased by 13.82% to $12.52. As of 12:30 EST, this security is trading at a volume of 263.6K shares, making up 130.46% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $80.0 million.</li>
<li>Vinco Ventures (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIG#NASDAQ">BBIG</a>) stock increased by 7.57% to $4.97. The current volume of 19.9 million shares is 216.84% of Vinco Ventures&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $207.5 million.</li>
<li>XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) stock rose 7.32% to $41.44. Trading volume for XPeng&#39;s stock is 11.9 million as of 12:30 EST. This is 76.32% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $33.2 billion.</li>
<li>Waitr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTRH#NASDAQ">WTRH</a>) stock moved upwards by 7.11% to $2.33. The current volume of 1.2 million shares is 52.98% of Waitr Hldgs&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $269.4 million.</li>
</ul>
&nbsp;
&nbsp;
<h3>Losers</h3>
&nbsp;
<ul>
<li>Trxade Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) stock fell 22.78% to $5.15 during Friday&#39;s regular session. Trading volume for Trxade Health&#39;s stock is 3.1 million as of 12:30 EST. This is 101.07% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $41.8 million.</li>
<li>Jiuzi Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) shares fell 12.61% to $8.3. As of 12:30 EST, this security is trading at a volume of 1.4 million shares, making up 32.99% of its average full-day volume over the last 100 days.</li>
<li>Gaotu Techedu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOTU#NYSE">GOTU</a>) shares decreased by 9.79% to $14.56. The current volume of 8.5 million shares is 88.37% of Gaotu Techedu&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST).</li>
<li>China Online Education Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COE#NYSE">COE</a>) stock fell 9.77% to $10.25. China Online Education Gr&#39;s stock is trading at a volume of 157.2K shares as of 12:30 EST. This is 267.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $220.4 million.</li>
<li>Full House Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLL#NASDAQ">FLL</a>) stock fell 8.48% to $9.39. As of 12:30 EST, this security is trading at a volume of 412.1K shares, making up 82.43% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $320.2 million.</li>
<li>RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) stock decreased by 7.46% to $36.09. As of 12:30 EST, this security is trading at a volume of 29.1K shares, making up 34.11% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $122.4 million.</li>
</ul>
&nbsp;
&nbsp;

GSX Techedu Inc. American Depositary Shares

GOTU

RMBL

WTRH

XPEV

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

Iconix Brand Group shares are trading higher after the company announced a deal to go private at $3.15 per share in cash.

Iconix Brand Shares Resume Trade, Up 27%

Icon Energy Corp. (ICON) has released an update. Icon Energy Corp. has reported a robust financial performance for the first half of 2024, with an ...

Icon Energy Corp. Soars with Strong H1 2024 Earnings

&nbsp;Icon Energy Corp. GAAP EPS of $4.56, revenue of $2.72M

Icon Energy Corp. (ICON – Research Report), the Energy sector company, was revisited by a Wall Street analyst yesterday. Analyst Tate Sullivan from...

Buy Rating Justified by Icon Energy Corp's Strong Financials and Positive Industry Outlook

Icon Energy Corp. (ICON) has released an update. Icon Energy Corp. has announced the delivery of the M/V Bravo, a Kamsarmax dry bulk carrier, along...

Icon Energy Expands Fleet and Secures Financing

Icon Energy Corp. declares $0.08 dividend

Reports 9M revenue $3.58M vs. $$3.25M last year. Ismini Panagiotidi, Chairwoman and CEO of Icon, commented: "We are pleased to announce our financi...

Icon Energy reports 9M EPS 6c vs. $3.76 last year

Icon's Board of Directors approved a cash dividend of $0.085 per common share for the third quarter of 2024. The cash dividend will be paid on or a...

Icon Energy board approves quarterly cash dividend of 8.5c per share

Icon Energy Corp. declares $0.085 dividend

Icon Energy GAAP EPS of $0.06, revenue of $3.58M

Icon Energy Corp. (ICON) has released an update. Icon Energy Corp. reported a 10% increase in revenue to $3.6 million for the first nine months of ...

Icon Energy Reports Revenue Growth and Dividend Announcement

Press Releases

Icon Energy Corp. Announces Listing on Nasdaq and Pricing of $5.0 Million Initial Public Offering

Icon Energy Corp. Announces Closing of $5.0 Million Initial Public Offering

Icon Energy Corp. Announces the Acquisition of a Kamsarmax Dry Bulk Carrier

Dividends

Icon Energy Corp. Announces Quarterly Cash Dividend of $0.08 per Common Share, Entering into a Financing Term Sheet, and Earnings Preview

Icon Energy Corp. Reports Financial Results for the Six-Month Period Ended June 30, 2024

Icon Energy Corp. Announces the Delivery of M/V Bravo and the Signing of a Term Loan Facility for up to $91.5 million

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now

Icon Energy Corp. Reports Financial Results for the Nine-Month Period Ended September 30, 2024, and Declares Cash Dividend of $0.085 per Common Share

Comments

Icon Energy

Icon Energy (ICON) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga